Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT05941520

Recruiting

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Breast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Breast Atypical Hyperplasia
NCT04084730

Recruiting

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Breast Cancer | DCIS | Invasive Ductal Carcinoma, Breast | Invasive Ductal Breast Carcinoma | DCIS Grade 1 | DCIS Grade 2
NCT07612215

Recruiting

Elacestrant in Advanced Triple Positive Breast Cancer

ER Positive, HER2 Positive Breast Cancer
NCT07575750

Not yet recruiting

Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA) (AROVAGUE)

Breast Cancer | Aromatase Inhibitor-induced Arthralgia
NCT07490509

Not yet recruiting

Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer (DOSABEMA)

Breast Cancer | Abemaciclib | Abemaciclib-related Diarrhea
NCT07461454

Recruiting

YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer

Locally Advanced or Metastatic Breast Cancer
NCT07401381

Not yet recruiting

A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer (SIE-1)

Hormone Receptor Positive Early Breast Cancer
NCT07394218

Recruiting

ctDNA-guided Treatment Decision-making

ctDNA | Metastatic Breast Cancer ( HER2 Negative)
NCT07354022

Recruiting

A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.

Locally Advanced or Metastatic Breast Cancer
NCT07294430

Not yet recruiting

Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate. (OASISImmunoPET)

Locally Advanced or Metastatic Breast Cancer
NCT07243418

Not yet recruiting

Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study

Breast Cancer | CTIT-Chemotherapy Induced Thrombocytopenia
NCT07195344

Recruiting

Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI. (TDXdose)

Locally Advanced or Metastatic Breast Cancers
NCT07190066

Recruiting

MELIORA Data Collection Campaigns (DCC)

Breast Cancer Prevention
NCT07162519

Not yet recruiting

Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients

Breast Cancer | Romiplostim N01 | Cytotoxic Drugs
NCT07132034

Not yet recruiting

Stress Reduction Through Acupuncture (STREAK)

Breast Cancer | Acupuncture | Survivorship
NCT07021911

Recruiting

Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer (COMBaRT)

Breast Cancer | Radiotherapy; Complications
NCT07005557

Not yet recruiting

Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer (SENIOR)

Breast Cancer | Adjuvant Therapy
NCT06609187

Recruiting

A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

Breast Cancer | Solid Tumor
NCT06493864

Recruiting

A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

Breast Cancer | Solid Tumor
NCT06398067

Recruiting

Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet Nam

Breast Cancer | Gynecologic Cancer
NCT06313073

Recruiting

Neoadjuvant Radiotherapy for Breast Cancer

Breast Cancer | Neoadjuvant Radiotherapy
NCT06272799

Recruiting

Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents. (ATD)

Breast Cancer
NCT05973864

Recruiting

Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery (CAPPA)

Triple Negative Breast Neoplasms
NCT05861635

Recruiting

The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression

Breast Cancer | Neoadjuvant Therapy
NCT05755048

Recruiting

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Breast Cancer
NCT05754502

Recruiting

Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy

Breast Cancer
NCT05253170

Not yet recruiting

Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients

Breast Cancer | Radiotherapy; Complications
NCT05251766

Not yet recruiting

Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer

Breast Cancer | Chemotherapy Effect
NCT05231863

Recruiting

Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world Study

Breast Cancer
NCT05212454

Recruiting

Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks

Breast Cancer | Chemotherapy Effect
NCT05067530

Not yet recruiting

Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a "Window of Opportunity" Study (CAREGIVER)

Triple Negative Breast Neoplasms
NCT04526028

Recruiting

Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China

Breast Cancer | Fulvestrant | Palbociclib
NCT03897270

Recruiting

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

Breast Carcinoma | Healthy Subject
NCT03463954

Recruiting

Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

Malignant Neoplasm of Breast
NCT05294016

Active, not recruiting

Smart Bra for Diagnosing Breast Cancer (CBRA)

Breast Cancer | Medical Device
NCT07428720

Active, not recruiting

Axillary Lymph Node Changes After Neoadjuvant Therapy In Breast Cancer

Breast Cancer | Axillary Lymph Node Metastasis
NCT04806724

Completed

Opening the Conversation Study

Breast Cancer | Gynecologic Cancer
NCT07376681

Enrolling by invitation

Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health

Breast Cancer | Fertility | Prognosis | Young People
NCT04319510

Completed

Supportive Effects of Craniosacral Therapy for Women With Breast Cancer (CRANIO4US)

Breast Cancer | Complementary Therapies
NCT01196936

Active, not recruiting

Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors (LDTam)

Breast Cancer
NCT07306130

Enrolling by invitation

Consensus on Skin Care in Breast Cancer Patients

Breast Cancer | Rejuvenation | Skin Care Dermocosmetics
NCT03997123

Active, not recruiting

Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC (CAPItello-290)

Triple Negative Breast Neoplasms
NCT02926196

Completed

Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab (A-Brave)

Triple Negative Breast Neoplasms
NCT03036488

Completed

Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)

Triple Negative Breast Neoplasms
NCT03529110

Active, not recruiting

DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]

Breast Cancer
NCT06131424

Completed

NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients (iRetroBC)

HER2-negative
NCT00070564

Active, not recruiting

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

Breast Cancer
NCT05806138

Active, not recruiting

A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

Breast Cancer | Cardiac Dysfunction
NCT05867667

Terminated

Cardiac Rehabilitation to Improve Breast Cancer Outcomes (CRIBCO)

Cardiovascular Diseases | Breast Cancer
NCT04440982

Terminated

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Breast Cancer | Neoadjuvant Therapy

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations